Which closed-end funds own Mineralys Therapeutics Inc?
5 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $18.7M. Security type: common equity. Country: United States. CUSIP 603170101 · ISIN US6031701013 · ticker MLYS.
Holdings are historical filings (report dates Jun 30, 2026 – Jul 31, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| HQH abrdn Healthcare Investors | Healthcare | 0.62% | $8.5M | 314,117 sh | $1.4B | 7.1% discount | Jun 30, 2026 |
| HQL abrdn Life Sciences Investors | Healthcare | 0.60% | $4.1M | 153,602 sh | $690M | 3.4% discount | Jun 30, 2026 |
| THQ abrdn Healthcare Opportunities Fund | Healthcare | 0.57% | $6M | 221,516 sh | $1.1B | 7.8% discount | Jun 30, 2026 |
| GRX Gabelli Healthcare & WellnessRx Trust | Healthcare | 0.07% | $162K | 6,000 sh | $228M | NAV unavailable | Jun 30, 2026 |
| BRW Saba Capital Income & Opportunities Fund | U.S. Equity | -0.00% | $-12.9K | -505 sh | $351M | 17.0% discount | Jul 31, 2026 |
5 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: MINERALYS THERAPEUTICS INC.
Issuer-level search for “MLYS” → · Compare two funds’ portfolios →